ARCHIVES

2008

2007

2006

2005

2004

Volume 3, Issue 6



Learn and Confirm: A Push for Adaptive Clinical Trial Design


Adaptive designs help get new drugs to market faster and more economically.


Tom Branna



Optimizing Drug Development Strategies


Here's a closer look at the drug development process in general, the importance of a comprehensive drug development plan and a risk management strategy for emerging drug companies.


Dr. Kenneth Sokoll



There’s Strength in Numbers


Collaboration is paramount to achieve innovation in the pharma and biopharma industry, insists Peter Corr, senior vice president, science and technology, Pfizer.


Tom Branna



Learn and Confirm: A Push for Adaptive Clinical Trial Design


Adaptive designs help get new drugs to market faster and more economically.


Tom Branna



Building a Successful Team


Teamwork is essential in the pharma and biopharma industry. Here's how to create a winning combination of talent.


Patrick B. Ropella



Globalization of Fine Chemicals


Despite dire warnings, most fine chemical producers have developed an Asian strategy in order to compete in the fast-changing global pharmaceutical market.


Tom Branna



Pharma/Bio Procurement Strategies


Whether your company is 20 years old or more than 100, developing the correct procurement strategies directly affects its long-term success.


Tom Branna



Volume 3, Issue 5



Optimizing Drug Development Strategies


Here's a closer look at the drug development process in general, the importance of a comprehensive drug development plan and a risk management strategy for emerging drug companies.


Dr. Kenneth Sokoll



Ensuring the Safety of Excipients


Read on to learn how Cognis implemented a wide range of good manufacturing practices for excipient manufacturing.


Jochen Seifert, Cognis Deutschland GmbH Co. KG



A Big Year for Biotech


The segment surpassed $60 billion in 2005, according Ernst & Young.


Parthasarathy Devaraj



Prepare for Victory: Mental Exercise is the Key to Success


How you handle adversity greatly affects your career


Patrick B. Ropella



Volume 3, Issue 4



A Pause in the Growth of Generics?


Big Pharma goes on the defensive as blockbuster patents expire.


Tom Branna



Avoiding the Pitfalls of Job Offers in the Pharmaceutical Industry


Patrick B. Ropella



Volume 3, Issue 3



VioQuest Pharamaceuticals Has the Bases Covered with Its Novel Business Plan


By offering pharmaceutical ingredients and developing finished products, VioQuest provides products and services to fine chemical manufacturers and 12 of the top 18 pharmaceutical companies worldwide.


David Savastano



How to Help Your Employees Avoid Failure


There are several reasons why employees fail in the work environment. Here’s how to avoid them and keep your workplace thriving.


Patrick B. Ropella



Volume 3, Issue 2



Biopharmaceuticals - What the Future Holds?


A. N. Aditya



Pathway Analysis in Drug Development


The drive of the drug discovery industry toward personalized medicine necessitates the development of a pathway analysis infrastructure.


Azat Badretdinov, Anton Yuryev



Sleeper Diseases


Forecast and Assessment of Neglected Disease Market Opportunities


Hermann A.M. Mucke, Ph.D.



Volume 3, Issue 1



Tabletting Tips


There are many factors to consider when manufacturing pharmaceutical tablets. Here’s help on how to choose the correct production method and tips on the impact that some common excipients can have on the final formulation.


Prafull K. Shiromani, Ph.D



Taxane APIs: Natural, Synthetic or Both?


When it comes to manufacturing paclitaxel and docetaxel active pharmaceutical ingredients, access to both natural and synthetic routes creates the strongest supply position.


Paul Metz



API Update


Overcapacity, pricing pressures and continued threats from competition in India and China impact the active pharmaceutical industry. But several suppliers insist that new strategies will help them compete in this increasingly complex market.


Tom Branna



A Big Year Ahead For API Regulations


Last year was a notable one for API regulatory guidelines, as the measures passed in 2005 are sure to have a major impact on the market this year.


Ambrose Stafford